Drugs & Medical Devices

Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.



Issue #3, March 2002

Plaintiffs Failed to Show Zoloft Misrepresentation Caused Boy's Suicide, Kansas Judge Rules

Plaintiffs claiming that defendant Pfizer's alleged misrepresentation of the antidepressant Zoloft caused or contributed to their 13-year-old son's suicide have not shown general or proximate causation

Lamisil's Liver Toxicity Warnings Were Adequate, Fifth Circuit Rules

The plaintiff had developed cholestatic hepatitis after beginning a 12-week course of Lamisil, which his dermatologist prescribed for the treatment of his chronic toenail fungus infection

Court Rules Joinder of Metabolife Distributors Not Fraudulent

A federal district court has ruled that two independent distributors of Metabolife named in a product liability suit were not fraudulently joined

Bayer Denies Allegations in Class Action, Asserts Class Certification Is Improper

Drugmaker Bayer Corp. has filed its answer to a plaintiff's class action complaint denying all allegations and asserting, among others, an affirmative defense that no common questions

Discovery and Trial Schedule Set in New Jersey State Rezulin Litigation

A New Jersey district court has set a loose schedule of events for its consolidated Rezulin litigation following a recent case management conference

OxyContin Time-Release Feature Flawed, Lawsuit Alleges

The complaint alleges that the defendants concealed their knowledge of the flaw and significantly downplayed the addiction risks of OxyContin

Documents Produced by Clinical Investigators for Rezulin MDL Protected

The federal court in New York overseeing Rezulin multidistrict litigation has set forth guidelines to ensure that certain documents produced by clinical investigators

Plaintiffs in a Metabolife 356 Case Fail to Establish Predominance, District Court Denies Class Certification

According to a Jan. 25 decision, the plaintiffs' request for class certification in a Metabolife 356 product liability case has been denied because predominance was not established.

Lawsuit Filed Against S.C. Doctors, Pharmacists, and Manufacturers of OxyContin

A Jan. 28 lawsuit alleges that the S.C. doctors and pharmacists that prescribed OxyContin, along with the companies that manufacture and distribute the drug, caused the plaintiffs to suffer death, addiction and withdrawal symptoms.

American Home Products Reaches Settlement in Tainted Arthritis Drug Case

Parties in a case that alleged an arthritis drug was contaminated with a beta blocker, causing the plaintiff to suffer from an overdose

Past Issues:


The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.